Our understanding of the physiology of the growth hormone-insulin-like grow
th factor (GH-IGF) axis has been characterized by remarkable advances in th
e past decade, with clarification of genetic defects in the development of
somatotropes, GH secretion and action, and IGF synthesis and action. Combin
ed efforts of research in this area and the development of animal models of
growth retardation have also indicated new genetic abnormalities that migh
t prove to cause short stature in humans. Genetic defects, both established
and hypothetical, ave reviewed, and a pragmatic clinical approach to the g
eneric investigation of short-statured patients is presented.